Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016809
Chunk: 105

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 105
---
 applicable or is shown in the financial statements or
the notes thereto.

| Item 9. | Undertakings |

The undersigned Registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this 
 registration statement:                                                                                |

| (i) | to include any prospectus required by section 10(a)(3) of the Securities Act; |

| (ii) | to reflect in the prospectus any facts or events arising after the effective date of the registration                                       
 statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change     
 in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities 
 offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or      
 high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule      
 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price    
 set forth in the “Calculation of Registration Fee” table in the effective registration statement; and                                       |

| (iii) | to include any material information with respect to the plan of distribution not previously disclosed   
 in the registration statement or any material change to such information in the registration statement; |

Provided, however,
that:

| (A) | Paragraphs (1)(i) and (1)(ii) of this section do not apply if the registration statement is on Form S-8,                                      
 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished 
 to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))  
 that are incorporated by reference in the registration statement; and                                                                         |

| (B) | Paragraphs (1)(i), (a)(1)(ii) and (1)(iii) of this section do not apply if the registration statement                                     
 is on Form S-3 or Form F-3 and the information required to be included in a post-effective amendment by those paragraphs is contained     
 in reports filed with or furnished to the Commission by the registrant pursuant to section